Article
Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease.
Journal of gastroenterology - 1 Mar 2018
Seko Yuya, Yamaguchi Kanji, Mizuno Naoki, Okuda Keiichiro, Takemura Masashi, Taketani Hiroyoshi, Hara Tasuku, Umemura Atsushi, Nishikawa Taichiro, Moriguchi Michihisa, Yasui Kohichiroh, Kamaguchi Mai, Nishioji Kenichi, Mochizuki Naomi, Kobayashi Masao, Mori Kojiroh, Tanaka Saiyu, Matsuura Kentaro, Tanaka Yasuhito, Itoh Yoshito
Abstract excerpt
BACKGROUND: Hepatic fibrosis is an independent risk factor for mortality and liver-related events in patients with nonalcoholic fatty liver disease (NAFLD). PNPLA3 rs738409 has been associated with fibrosis in viral and non-viral hepatitis. TLL1 rs17047200 also has been associated with developing hepatocellular carcinoma probably via hepatic fibrogenesis. We estimated the impact of these genetic polymorphisms on...
Read the complete abstract on PubMed